Cancer Research UK | A trial looking daratumumab and standard treatment for children and young adults with ALL or lymphoblastic lymphoma (Delphinus trial)

Please note

This trial is no longer recruiting patients. We hope to add results when they are available.

Overview

Cancer types:

Acute leukaemia, Acute lymphoblastic leukaemia (ALL), Blood cancers, Cell type, Children's cancers, Leukaemia, Lymphoma, Non-Hodgkin lymphoma (NHL)

Status:

Closed

Phase:

Phase 2

Details

This trial is for children and young people whose leukaemia or lymphoma has come back or treatment has stopped working.

It includes children and young adults up to the age of 30. We use the term ‘you’ in this summary. But if you are a parent, we are referring to your child.

Recruitment start: 5 June 2018

Recruitment end: 29 September 2021

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr John Moppett

Supported by

Janssen-Cilag

Last reviewed: 5 November 2021

CRUK internal database number: 15660

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Help and support

Questions for your doctor

What to ask your doctor about clinical trials.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.

A trial looking at daratumumab and standard treatment for children and young adults with acute lymphoblastic leukaemia or lymphoblastic lymphoma (Delphinus trial)